324 related articles for article (PubMed ID: 28861075)
1. Ebola Virus Glycoprotein Induces an Innate Immune Response
Lai CY; Strange DP; Wong TAS; Lehrer AT; Verma S
Front Microbiol; 2017; 8():1571. PubMed ID: 28861075
[TBL] [Abstract][Full Text] [Related]
2. Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins.
Lázaro-Frías A; Gómez-Medina S; Sánchez-Sampedro L; Ljungberg K; Ustav M; Liljeström P; Muñoz-Fontela C; Esteban M; García-Arriaza J
J Virol; 2018 Jun; 92(11):. PubMed ID: 29514907
[No Abstract] [Full Text] [Related]
3. To B or Not to B: Mechanisms of Protection Conferred by rVSV-EBOV-GP and the Roles of Innate and Adaptive Immunity.
Pinski AN; Messaoudi I
Microorganisms; 2020 Sep; 8(10):. PubMed ID: 32992829
[TBL] [Abstract][Full Text] [Related]
4. Matrix-M adjuvant enhances antibody, cellular and protective immune responses of a Zaire Ebola/Makona virus glycoprotein (GP) nanoparticle vaccine in mice.
Bengtsson KL; Song H; Stertman L; Liu Y; Flyer DC; Massare MJ; Xu RH; Zhou B; Lu H; Kwilas SA; Hahn TJ; Kpamegan E; Hooper J; Carrion R; Glenn G; Smith G
Vaccine; 2016 Apr; 34(16):1927-35. PubMed ID: 26921779
[TBL] [Abstract][Full Text] [Related]
5. Recombinant Modified Vaccinia Virus Ankara Generating Ebola Virus-Like Particles.
Schweneker M; Laimbacher AS; Zimmer G; Wagner S; Schraner EM; Wolferstätter M; Klingenberg M; Dirmeier U; Steigerwald R; Lauterbach H; Hochrein H; Chaplin P; Suter M; Hausmann J
J Virol; 2017 Jun; 91(11):. PubMed ID: 28331098
[TBL] [Abstract][Full Text] [Related]
6. Enhanced
Chabot S; Gimie Y; Obeid K; Kim J; Meseda CA; Konduru K; Kaplan G; Sheng Fowler L; Weir JP; Peden K; Major ME
J Virol; 2022 Sep; 96(18):e0116621. PubMed ID: 36069549
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic vaccination strategies against EBOV by rVSV-EBOV-GP: the role of innate immunity.
Pinski AN; Messaoudi I
Curr Opin Virol; 2021 Dec; 51():179-189. PubMed ID: 34749265
[TBL] [Abstract][Full Text] [Related]
8. Vesicular Stomatitis Virus Pseudotyped with Ebola Virus Glycoprotein Serves as a Protective, Noninfectious Vaccine against Ebola Virus Challenge in Mice.
Lennemann NJ; Herbert AS; Brouillette R; Rhein B; Bakken RA; Perschbacher KJ; Cooney AL; Miller-Hunt CL; Ten Eyck P; Biggins J; Olinger G; Dye JM; Maury W
J Virol; 2017 Sep; 91(17):. PubMed ID: 28615211
[TBL] [Abstract][Full Text] [Related]
9. Ebolaviruses Associated with Differential Pathogenicity Induce Distinct Host Responses in Human Macrophages.
Olejnik J; Forero A; Deflubé LR; Hume AJ; Manhart WA; Nishida A; Marzi A; Katze MG; Ebihara H; Rasmussen AL; Mühlberger E
J Virol; 2017 Jun; 91(11):. PubMed ID: 28331091
[TBL] [Abstract][Full Text] [Related]
10. Alphavirus Replicon DNA Vectors Expressing Ebola GP and VP40 Antigens Induce Humoral and Cellular Immune Responses in Mice.
Ren S; Wei Q; Cai L; Yang X; Xing C; Tan F; Leavenworth JW; Liang S; Liu W
Front Microbiol; 2017; 8():2662. PubMed ID: 29375526
[TBL] [Abstract][Full Text] [Related]
11. Antiviral Innate Responses Induced by VSV-EBOV Vaccination Contribute to Rapid Protection.
Menicucci AR; Jankeel A; Feldmann H; Marzi A; Messaoudi I
mBio; 2019 May; 10(3):. PubMed ID: 31138743
[TBL] [Abstract][Full Text] [Related]
12. Vaccination With a Highly Attenuated Recombinant Vesicular Stomatitis Virus Vector Protects Against Challenge With a Lethal Dose of Ebola Virus.
Matassov D; Marzi A; Latham T; Xu R; Ota-Setlik A; Feldmann F; Geisbert JB; Mire CE; Hamm S; Nowak B; Egan MA; Geisbert TW; Eldridge JH; Feldmann H; Clarke DK
J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S443-51. PubMed ID: 26109675
[TBL] [Abstract][Full Text] [Related]
13. Glucopyranosyl lipid adjuvant enhances immune response to Ebola virus-like particle vaccine in mice.
Sunay MME; Martins KAO; Steffens JT; Gregory M; Vantongeren SA; Van Hoeven N; Garnes PG; Bavari S
Vaccine; 2019 Jun; 37(29):3902-3910. PubMed ID: 31174937
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity of propagation-restricted vesicular stomatitis virus encoding Ebola virus glycoprotein in guinea pigs.
Locher S; Schweneker M; Hausmann J; Zimmer G
J Gen Virol; 2018 Jul; 99(7):866-879. PubMed ID: 29869979
[TBL] [Abstract][Full Text] [Related]
15. VSVΔG/EBOV GP-induced innate protection enhances natural killer cell activity to increase survival in a lethal mouse adapted Ebola virus infection.
Williams KJ; Qiu X; Fernando L; Jones SM; Alimonti JB
Viral Immunol; 2015 Feb; 28(1):51-61. PubMed ID: 25494457
[TBL] [Abstract][Full Text] [Related]
16. Randomized, Blinded, Dose-Ranging Trial of an Ebola Virus Glycoprotein Nanoparticle Vaccine With Matrix-M Adjuvant in Healthy Adults.
Fries L; Cho I; Krähling V; Fehling SK; Strecker T; Becker S; Hooper JW; Kwilas SA; Agrawal S; Wen J; Lewis M; Fix A; Thomas N; Flyer D; Smith G; Glenn G
J Infect Dis; 2020 Jul; 222(4):572-582. PubMed ID: 31603201
[TBL] [Abstract][Full Text] [Related]
17. Intranasal vaccination with ebola virus GP amino acids 258-601 protects mice against lethal challenge.
Su QD; He SH; Yi Y; Qiu F; Lu XX; Jia ZY; Meng QL; Fan XT; Tian RG; Audet J; Qiu XG; Bi SL
Vaccine; 2018 Oct; 36(41):6053-6060. PubMed ID: 30195490
[TBL] [Abstract][Full Text] [Related]
18. Extracellular vesicle storm during the course of Ebola virus infection in primates.
Vucetic A; Lafleur A; Côté M; Kobasa D; Chan M; Alvarez F; Piccirillo C; Dong G; Olivier M
Front Cell Infect Microbiol; 2023; 13():1275277. PubMed ID: 38035334
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the protective efficacy of DNA and baculovirus-derived protein vaccines for EBOLA virus in guinea pigs.
Mellquist-Riemenschneider JL; Garrison AR; Geisbert JB; Saikh KU; Heidebrink KD; Jahrling PB; Ulrich RG; Schmaljohn CS
Virus Res; 2003 Apr; 92(2):187-93. PubMed ID: 12686428
[TBL] [Abstract][Full Text] [Related]
20. IL-4/IL-13 polarization of macrophages enhances Ebola virus glycoprotein-dependent infection.
Rogers KJ; Brunton B; Mallinger L; Bohan D; Sevcik KM; Chen J; Ruggio N; Maury W
PLoS Negl Trop Dis; 2019 Dec; 13(12):e0007819. PubMed ID: 31825972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
